search
Back to results

Reducing Asthma Disparities by Improving Provider-Patient Communication

Primary Purpose

Asthma

Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Asthma Control and Communication Instrument
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Asthma focused on measuring Asthma

Eligibility Criteria

12 Years - 85 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: are able to provide informed consent; report physician-diagnosed asthma; report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month. Exclusion Criteria: state they do not have asthma; have mild intermittent disease no recent evidence of disease activity.

Sites / Locations

  • Johns Hopkins Asthma And Allergy Center

Outcomes

Primary Outcome Measures

Accuracy of Provider Assessment of Asthma Severity
Accuracy of Clinician Assessment of Patient Adherence
Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines
Patient satisfaction with provider-patient communication and medical care

Secondary Outcome Measures

These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.

Full Information

First Posted
September 13, 2005
Last Updated
August 17, 2018
Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00181194
Brief Title
Reducing Asthma Disparities by Improving Provider-Patient Communication
Official Title
Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy
Study Type
Observational

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
May 2005 (undefined)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.
Detailed Description
Improving communication between health care providers and their patients is the critical first step in efforts designed to reduce asthma-related health disparities in urban areas. Improving communication will help providers tailor asthma therapies to their patients' needs, and help providers and patients to overcome barriers (e.g., concerns about adverse effects) to adherence with those asthma treatment plans.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma

7. Study Design

Enrollment
350 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Asthma Control and Communication Instrument
Primary Outcome Measure Information:
Title
Accuracy of Provider Assessment of Asthma Severity
Title
Accuracy of Clinician Assessment of Patient Adherence
Title
Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines
Title
Patient satisfaction with provider-patient communication and medical care
Secondary Outcome Measure Information:
Title
These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: are able to provide informed consent; report physician-diagnosed asthma; report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month. Exclusion Criteria: state they do not have asthma; have mild intermittent disease no recent evidence of disease activity.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory B Diette, MD, MHS
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Asthma And Allergy Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Reducing Asthma Disparities by Improving Provider-Patient Communication

We'll reach out to this number within 24 hrs